Authors
Loading...
Findings reveal menin inhibition boosts CD11b expression in NPM1 and KMT2A leukemias, enhancing CAR-T effectiveness.
Habermann et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: